Deregulated expression of the TAL1 gene by t(1;5)(p32;q31) in patient with T-cell acute lymphoblastic leukemia

Genes Chromosomes and Cancer

Volumn 23, Issue 1, 1998, Pages 36-43

  François, Sylvie ^a   Delabesse, Eric ^b   Baranger, Laurence ^a   Dautel, Marie ^a   Foussard, Charles ^a   Boasson, Marc ^a   Blanchet, Odile ^a   Bernard, Olivier ^c   Macintyre, Elizabeth A ^b   Ifrah, Norbert ^a  

^a HÔTEL DIEU   (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME 1; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CYTOGENETICS; GENE CONTROL; GENE EXPRESSION; GENE TRANSLOCATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0344333431     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199809)23:1<36::AID-GCC6>3.0.CO;2-7     Document Type: Article

References (42)

1. Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL, Kirsch I (1990) Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 250:1426-1429.
2. Aplan PD, Lombardi DP, Kirsch I (1991) Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia. Mol Cell Biol 11:5462-5469.
3. Aplan PD, Lombardi DP, Reeman GH, Sather HN, Hammond GD, Kirsch I (1992a) Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79:1327-1333.
4. Aplan PD, Nakahara K, Orkin SH, Kirsch IR (1992b) The SCL gene product: A positive regulator of erythroid differentiation. EMBO J 11:4073-4081.
5. Aplan PD, Raimondi SC, Kirsch IR (1992c) Disruption of the SCL gene by a t(1;3) translocation in a patient with T-cell acute lymphoblastic leukemia. J Exp Med 176:1303-1310.
6. Aplan PD, Johnson BE, Russell E, Chervinsky DS, Kirsch IR (1995) Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation. Cancer Res 55:1917-1921.
7. Bash RO, Hall S, Timmons CF, Crist WM, Amylon M, Smith RG, Baer R (1995) Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Blood 86:666-676.
8. Begley CG, Aplan PD, Davey MP, Nakahara K, Tchorz K, Kurtzberg J, Hershfield MS, Haynes BF, Cohen DI, Waldmann TA, Kirsch IR (1989) Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptot S-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA 90:2031-2035.
9. Bernard O, Guglielmi P, Jonveaux P, Cherif D, Gisselbrecht S, Mauchauffé M, Berger R, Larsen C-J, Mathieu-Mahul D (1990) Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer 1:194-208.
10. Bernard O, Lecointe N, Jonveaux P, Souyri M, Mauchauffé M, Berger R, Larsen C-J, Mathieu-Mahul D (1991) Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 6:1477-1488.
11. Bernard O, Azogui O, Lecointe N, Mugneret F, Berger R, Larsen CJ, Mathieu-Mahul D (1992) A third tal-1 promoter is specifically used in human T-cell leukemia. J Exp Med 176:919-925.
12. Bernard O, Barin C, Charrin C, Mathieu-Mahul D, Berger R (1993) Characterization of translocation t(1;14)(p32;q11) in a T-acute and in a B-acute leukemia. Leukemia 7:1509-1513.
13. Breit TM, Mol EJ, Wolverstettero ILM, Ludwig WD, Vanwering ER, Vandongen JJM (1993) Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T-cell receptor alpha/beta lineage: T-cell receptor-delta gene deletion mechanism affects multiple genes. J Exp Med 177:965-977.
14. Brown L, Cheng J-T, Chen Q, Siciliano M, Crist W, Buchanan G, Baer R (1990) Site-specific recombination of the tal-1 gene is a common occurence in human T-cell leukemia. EMBO J 9:3343-3351.
15. Carroll AJ, Crist WM, Link MP, Amylon MD, Pullen DJ, Ragab AH, Buchanan G, Wimmer RS, Vietti TJ (1990) The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 76:1220-1224.
16. Chen Q, Yang CYC, Tsan JT, Xia Y, Ragab AM, Peiper SC, Carroll A, Baer R (1990) Cording sequences of the tal-1 gene are disrupted by chromosomal translocation in human T-cell leukemia. J Exp Med 172:1403-1408.
17. Chetty R, Pulford K, Jones M, Mathieu-Mahul D, Close P, Hussein S, Palleseng, Ralfkiaer E, Steinh, Gatter K. (1995) SCL/Tal-1 expression in T-acute lymphoblastic leukemia: An immunohistochemical and genotypic study. Hum Pathol 26:994-998.
18. l variants. Br J Haematol 99:901-907.
19. Fitzgerald TJ, Neale GAM, Raimondi SC, Goorha RM (1991) c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32; q35). Blood 78:2686-2695.
20. Gibson S, Leung B, Squire JA, Hill M, Arima N, Goss P, Hogg D, Mills GB (1993) Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q. Blood 82:1561-1572.
21. Green AR, DeLuca E, Begley CG (1991) Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. Embo J 10:4153-4158.
22. Hsu HL, Cheng JT, Chen Q, Baer RJ (1991) Enhancer-binding activity of the TAL-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol Cell Biol 11:3037-3042.
23. Hsu HL, Huang L, Tsan JT, Funk W, Wright WE, Hu JS, Kingston RE, Baer R (1994a) Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol 14:1256-1265.
24. Hsu HL, Wadman I, Baer R (1994b) Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T-cells. Proc Natl Acad Sci USA 91:3181-3185.
25. Hsu HL, Wadman I, Tsan JT, Baer R (1994c) Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc Natl Acad Sci USA 91:5947-5951.
26. Huang W, Kuang SQ, Huang QH, Dong S, Zhang T, Gu LJ, Ching LM, Chen SJ, Chang LC, Chen Z. (1995) RT-PCR detection of SIL-Tal-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL). Cancer Genet Cytogenet 81:76-82.
27. Kallianpur AR, Jordan JE, Brandt SJ (1994) The SCL/Tal-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83:1200-1208.
28. Kelliher MA, Seldin DC, Leder P (1996) Tal-1 induces T-cell acute lymphoblastic leukemia accelerated by casein kinase II alpha. EMBO J 15:5160-5166.
29. Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I, Nottage K, Rabbitts TH (1996) Protein dimerization between Imo2 (Rbtn2) and tal1 alters thymocyte development and potentiates T-cell tumorigenesis in transgenic mice. EMBO J 15:1021-1027.
30. Leroy-Viard K, Vinit MA, Lecointe N, Mathieu-Mahul D, Romeo PH (1994) Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines. Blood 84:3819-3827.
31. d occurs in ab but not gd expressing T-ALLs. Blood 78:267a,1058.
32. Macintyre EA, Smit L, Ritz J, Kirsch IR, Strominger JL (1992) Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor-ab lineage. Blood 80:1511-1520.
33. Mitelman F (ed) (1995) ISCN 1995: An International System for Human Cytogenetic Nomenclature - Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Basel: S. Karger.
34. Mouthon MA, Bernard O, Mitjavila MT, Romeo PH, Vainchenker W, Mathieu-Mahul D (1993) Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81:647-655.
35. Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C, Leboeuf D, Bastard C, Picard F, Veil-Buzyn A, Flandrin G, Bernard O, Macintyre E. (1996) Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia m1 and m5. Blood 87:2496-2505.
36. Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH (1996) The T-cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86:47-57.
37. Pulford K, Lecointe N, Leroy-Viard K, Jones M, Mathieu-Mahul D, Mason DY (1995) Expression of TAL-1 proteins in human tissues. Blood 85:675-684.
38. Robb L, Rasko JEJ, Bath ML, Strasser A, Begley CG (1995) SCL, a gene frequently activated in human T-cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene 10:205-209.
39. Robb L, Elwood NJ, Elefanty AG, Kontgen F, Li RL, Barnett LD, Begley CG (1996) The SCL gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J 15:4123-4129.
40. Shivdasani RA, Mayer EL, Orkin SH (1995) Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/ SCL. Nature 373:432-434.
41. Stock W, Westbrook CA, et al. (1995) Low incidence of TAL1 gene rearrangements in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762). Clinical Cancer Research 1:459-463.
42. van de Wetering M, Oosterwegel M, Holstege F, Dooyes D, Suijkerbuijk R, Geurts van Kessel A, Clevers H (1992) The human T-cell transcription factor-1 gene: Structure, localization, and promoter characterization. J Biol Chem 267:8530-8536.